-
Astellas announces EC approval of Xtandi for expanded prostate cancer use
25 Apr 2024 11:38 GMT
… for castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer, the first … the disease still responds to testosterone-lowering treatments.
However, up … who have undergone definitive prostate cancer treatment will experience BCR …
-
Biomarker vs MRI-Enhanced Strategies for Prostate Cancer Screening: The STHLM3-MRI Randomized Clinical Trial.
25 Apr 2024 07:49 GMT
… of prostate cancer. Participants underwent blood sampling for PSA and Stockholm3 tests … to estimate their risk of clinically significant prostate cancer (Gleason … score ≥3 + 4). After the blood tests were …
-
EC grants label extension approval for Astellas' Xtandi for use in additional recurrent early prostate cancer treatment setting
25 Apr 2024 06:20 GMT
… to lower testosterone levels. Of men who have undergone definitive prostate cancer treatment … -sensitive prostate cancer (mHSPC), metastatic castration-resistant prostate cancer (mCRPC), non-metastatic castration-resistant prostate cancer …
-
Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study
24 Apr 2024 23:09 GMT
ADT in PC patients leads to an increase in fat mass and to a decrease in lean mass, thus increasing the risk of sarcopenic obesity. In addition, ADT has also a negative impact on skeletal fragility, which increases the risk of fractures. During the recent …
-
FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical…
24 Apr 2024 20:02 GMT
… metastatic castration resistant prostate cancer have been … Genitourinary Cancer – Prostate, Testicular, and Penile
Title: A … with metastatic castration resistant prostate cancer (mCRPC).
Presenter: … metastatic castration-resistant prostate cancer. This program …
-
Masturbation can lower prostate cancer risk: expert
24 Apr 2024 19:40 GMT
… might keep prostate cancer at bay. Prostate cancer is the … ejaculation can reduce prostate cancer by decreasing the … testosterone and a heightened risk of prostate cancer.
Men with lower testosterone … ejaculation frequency and prostate cancer is not fully …
-
Masturbating might slash risk of prostate cancer, claims expert (and more is better!)
24 Apr 2024 12:48 GMT
… may help protect against prostate cancer.
Dr Kelly wrote: … ejaculation can reduce prostate cancer by decreasing the … does it develop?
Prostate cancer usually develops slowly, … erectile dysfunction.
Tests and treatment
Tests for prostate cancer are haphazard …
-
EC approves Astellas’ Xtandi for high-risk prostate cancer treatment
24 Apr 2024 11:23 GMT
… BCR) non-metastatic hormone-sensitive prostate cancer (nmHSPC) who are not … BCR and is a testament to our long and … early, recurrent hormone-sensitive prostate cancer setting. Astellas is in … non-metastatic castration-sensitive prostate cancer with BCR at high …
-
Signs and Symptoms of Low Testosterone in Men
25 Apr 2024 00:56 GMT
… testosterone levels will decrease.
Some of the side effects be:
Acne
Prostate cancer … has increased
shrinking testicles
lower number of sperm … has not been treated
Have prostate cancer or breast cancer.
Have sleep …
-
Racial and Ethnic Variation in Receipt and Intensity of Active Surveillance for Older Patients With Localized Prostate Cancer.
24 Apr 2024 08:24 GMT
… active surveillance (AS) for prostate cancer is increasing, and racial … and favorable intermediate-risk prostate cancer, with particular focus on … or favorable intermediate-risk prostate cancer. The odds of receiving … of usage of PSA tests, biopsy, and mpMRI …